112 related articles for article (PubMed ID: 11857534)
41. PCR-RFLP-detected human papilloma virus infection in a group of senegalese women attending an STD clinic and identification of a new HPV-68 subtype.
Astori G; Beltrame A; Pipan C; Raphenon G; Botta GA
Intervirology; 1999; 42(4):221-7. PubMed ID: 10567840
[TBL] [Abstract][Full Text] [Related]
42. Prevalence, evolution, and features of infection with human papillomavirus: a 15-year longitudinal study of routine screening of a women population in the north of Spain.
de Oña M; Alvarez-Argüelles ME; Torrents M; Villa L; Rodriguez-Feijoo A; Palacio A; Boga JA; Tamargo A; Melón S
J Med Virol; 2010 Apr; 82(4):597-604. PubMed ID: 20166173
[TBL] [Abstract][Full Text] [Related]
43. Time trends in the prevalence of human papillomavirus infections in archival Papanicolaou smears: analysis by cytology, DNA hybridization, and polymerase chain reaction.
Rakoczy P; Sterrett G; Kulski J; Whitaker D; Hutchinson L; MacKenzie J; Pixley E
J Med Virol; 1990 Sep; 32(1):10-7. PubMed ID: 2173733
[TBL] [Abstract][Full Text] [Related]
44. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
[TBL] [Abstract][Full Text] [Related]
45. Prevalence and type distribution of human papillomavirus infection using the INNo-Lipa assay, Kerman, Southeast Iran.
Afshar RM; Mollaie HR; Fazlalipour M; Arabzadeh SA
Asian Pac J Cancer Prev; 2013; 14(9):5287-91. PubMed ID: 24175815
[TBL] [Abstract][Full Text] [Related]
46. Type-specific human papillomavirus distribution in invasive cervical carcinomas in Paraguay. A study of 432 cases.
Kasamatsu E; Cubilla AL; Alemany L; Chaux A; Tous S; Mendoza L; Paez M; Klaustermeier JE; Quint W; Lloveras B; de Sanjose S; Muñoz N; Bosch FX
J Med Virol; 2012 Oct; 84(10):1628-35. PubMed ID: 22930512
[TBL] [Abstract][Full Text] [Related]
47. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method.
Gravitt PE; Peyton CL; Apple RJ; Wheeler CM
J Clin Microbiol; 1998 Oct; 36(10):3020-7. PubMed ID: 9738060
[TBL] [Abstract][Full Text] [Related]
48. Human papillomavirus typing with GP5+/6+ polymerase chain reaction reverse line blotting and with commercial type-specific PCR kits.
Gillio-Tos A; De Marco L; Ghisetti V; Snijders PJ; Segnan N; Ronco G; Merletti F
J Clin Virol; 2006 Jun; 36(2):126-32. PubMed ID: 16624614
[TBL] [Abstract][Full Text] [Related]
49. Human papillomavirus prevalence and genotypes distribution among female outpatients in Qingdao, East China.
Bi Q; Zhang L; Zhao Z; Mu X; Zhang M; Wang P
J Med Virol; 2015 Dec; 87(12):2114-21. PubMed ID: 26069229
[TBL] [Abstract][Full Text] [Related]
50. High-risk HPV types in lesions of the uterine cervix of female commercial sex workers in the Philippines.
Miyashita M; Agdamag DM; Sasagawa T; Matsushita K; Salud LM; Salud CO; Saikawa K; Leano PS; Pagcaliwagan T; Acuna J; Ishizaki A; Kageyama S; Ichimura H
J Med Virol; 2009 Mar; 81(3):545-51. PubMed ID: 19152419
[TBL] [Abstract][Full Text] [Related]
51. Short-term fluctuations in the detection of cervical human papillomavirus DNA.
Wheeler CM; Greer CE; Becker TM; Hunt WC; Anderson SM; Manos MM
Obstet Gynecol; 1996 Aug; 88(2):261-8. PubMed ID: 8692513
[TBL] [Abstract][Full Text] [Related]
52. [PCR-based sequencing for detection and genotyping of human papillomavirus in 325 cervical cell specimens from Beijing area].
Cai Y; Zhang R; Li Y; Xia X; Xiang Y; Zhu B; Yang Y
Sheng Wu Gong Cheng Xue Bao; 2011 Oct; 27(10):1482-9. PubMed ID: 22260065
[TBL] [Abstract][Full Text] [Related]
53. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis.
Clifford GM; Gallus S; Herrero R; Muñoz N; Snijders PJ; Vaccarella S; Anh PT; Ferreccio C; Hieu NT; Matos E; Molano M; Rajkumar R; Ronco G; de Sanjosé S; Shin HR; Sukvirach S; Thomas JO; Tunsakul S; Meijer CJ; Franceschi S;
Lancet; 2005 Sep 17-23; 366(9490):991-8. PubMed ID: 16168781
[TBL] [Abstract][Full Text] [Related]
54. Determinants of low-risk and high-risk cervical human papillomavirus infections in Montreal University students.
Richardson H; Franco E; Pintos J; Bergeron J; Arella M; Tellier P
Sex Transm Dis; 2000 Feb; 27(2):79-86. PubMed ID: 10676974
[TBL] [Abstract][Full Text] [Related]
55. Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study.
McGregor S; Saulo D; Brotherton JML; Liu B; Phillips S; Skinner SR; Luey M; Oliver L; Stewart M; Tabrizi SN; Garland S; Kaldor JM
Vaccine; 2018 Jul; 36(29):4311-4316. PubMed ID: 29880245
[TBL] [Abstract][Full Text] [Related]
56. Detection and typing of human papillomavirus in biopsy and cytological specimens by polymerase chain reaction and restriction enzyme analysis: a method suitable for semiautomation.
Adams V; Moll C; Schmid M; Rodrigues C; Moos R; Briner J
J Med Virol; 1996 Feb; 48(2):161-70. PubMed ID: 8835350
[TBL] [Abstract][Full Text] [Related]
57. Persistent HPV infection in postmenopausal age women.
Smith EM; Johnson SR; Ritchie JM; Feddersen D; Wang D; Turek LP; Haugen TH
Int J Gynaecol Obstet; 2004 Nov; 87(2):131-7. PubMed ID: 15491557
[TBL] [Abstract][Full Text] [Related]
58. Human papillomavirus: a highly prevalent sexually transmitted disease agent among female sex workers from Mexico City.
Juárez-Figueroa LA; Wheeler CM; Uribe-Salas FJ; Conde-Glez CJ; Zampilpa-Mejía LG; García-Cisneros S; Hernández-Avila M
Sex Transm Dis; 2001 Mar; 28(3):125-30. PubMed ID: 11289192
[TBL] [Abstract][Full Text] [Related]
59. Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study.
Karlsson R; Jonsson M; Edlund K; Evander M; Gustavsson A; Bodén E; Rylander E; Wadell G
Sex Transm Dis; 1995; 22(2):119-27. PubMed ID: 7624813
[TBL] [Abstract][Full Text] [Related]
60. Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination.
Trottier H; Mahmud S; Prado JC; Sobrinho JS; Costa MC; Rohan TE; Villa LL; Franco EL
J Infect Dis; 2008 May; 197(10):1436-47. PubMed ID: 18419547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
